Clinical trial

LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)

NCT04762992

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2022-07-18

PhasePHASE3

Study timeline

Study start (actual)2022-07-18Date precision: day

Registry last updated2025-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Fetal Growth Retardationunresolved

Prematurityunresolved

Pre-Eclampsiaunresolved

Interventions

subcutaneous EnoxaparinDRUG

standard of careOTHER

Sponsors & collaborators

Centro Hospitalar de Lisboa Centrallead sponsor

NOVA Medical Schoolcollaborator

Mapped research locations

LisbonPortugal1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04762992 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.